Trial intelligence / Profile preview

Dexmedetomidine vs ketamine vs pethidine for prevention of shivering during spinal anesthesia

IRCT20170101031697N3Phase 3Completed

Sponsor
Hormozgan University of Medical Sciences
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of dexmedetomidine, ketamine and pethidine (4 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoint: Degree of shivering. Started Mar 2016; status: completed.

02

Drugs

dexmedetomidineketaminepethidine

Beyond the preview

Go deeper on IRCT20170101031697N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170101031697N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call